Fenwal Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Fenwal Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011723
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fenwal Inc (Fenwal), a subsidiary of Fresenius Kabi AG is a blood technology company that supports transfusion medicine and cell therapies. The company’s products include amicus separator, blood pack units with whole blood filter, mononuclear cell collection, alyx component collection system, aurora plasmapheresis system, blood-pack units with red cell filter, hospital products and blood and plasma center products. It offers products for use in the practice of transfusion medicine, making life-saving blood therapies. Fenwal also provides services such as data management, customer solutions, production management and forecasting tools. The company serves blood centers, hospital blood banks and plasma collection centers. Fenwal is headquartered in Lake Zurich, Illinois, the US.

Fenwal Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fenwal Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fenwal Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fenwal Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fenwal Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Fenwal Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fenwal Inc, Medical Equipment, Deal Details 10
Partnerships 10
HemaTerra Technologies Enters Into Co-Development Agreement With Fenwal 10
Fenwal Enters Into Co-Marketing Agreement With Applied Science 11
Fenwal Enters Into Co-Marketing Agreement With Biolog-id For RFID Blood Tracking System 12
Fenwal Enters Into Co-Marketing Agreement With Genesis BPS 13
Acquisition 14
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 14
Fenwal Inc – Key Competitors 16
Fenwal Inc – Key Employees 17
Fenwal Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Fenwal Inc, Medical Equipment, Key Facts 2
Fenwal Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Fenwal Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fenwal Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fenwal Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fenwal Inc, Deals By Market, 2011 to YTD 2017 8
Fenwal Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
HemaTerra Technologies Enters Into Co-Development Agreement With Fenwal 10
Fenwal Enters Into Co-Marketing Agreement With Applied Science 11
Fenwal Enters Into Co-Marketing Agreement With Biolog-id For RFID Blood Tracking System 12
Fenwal Enters Into Co-Marketing Agreement With Genesis BPS 13
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 14
Fenwal Inc, Key Competitors 16
Fenwal Inc, Key Employees 17
Fenwal Inc, Subsidiaries 18
Fenwal Inc, Joint Venture 18

★海外企業調査レポート[Fenwal Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • S.Ishimitsu & Co.,Ltd. (2750):企業の財務及び戦略的SWOT分析
    Summary S.Ishimitsu & Co.,Ltd. (Ishimitsu) is a food product company that imports, exports and sells coffee beans, liquor, machinery, equipment, sundries, foodstuffs, confectionery and paper products. The company’s products include green coffee beans and coffee products, instant coffee, black tea, c …
  • Polartechnics Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Polartechnics Limited Mergers a …
  • Domtar Corporation:戦略・SWOT・企業財務分析
    Domtar Corporation - Strategy, SWOT and Corporate Finance Report Summary Domtar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sorgenia SpA:企業のM&A・提携動向(発電分野)
    Summary Sorgenia SpA (Sorgenia) is an electricity generator and energy utilities company. The company operates in the energy and natural gas sector. It produces, imports, and sells electricity and gas. The company also offers various integrated power saving equipments and services. Sorgenia is a gro …
  • Jersey Oil and Gas Plc (TRAP):企業の財務及び戦略的SWOT分析
    Summary Jersey Oil and Gas Plc (Jersey Oil) is an oil and gas company that focuses on the exploration, appraisal, and development and production in the UK continental shelf. It operates in a single geographical location in the North Sea of the UK. The company portfolio of oil and gas assets include …
  • Kyung-In Synthetic Corporation (012610):企業財務及び戦略的SWOT分析
    Summary Kyung-In Synthetic Corporation (Kyung-In) is a chemical company that offers research and development of reactive, disperse, fluorescent and acidic chemical dyes. The company offers products such as disperse dye, direct dye, acid dye, leather dye, fluorescent brightener, solvent, electronic m …
  • Green Plains Inc. (GPRE):企業のM&A・提携動向(石油・ガス分野)
    Summary Green Plains Inc. (Green Plains), formerly Green Plains Renewable Energy, Inc., is a vertically-integrated ethanol manufacturing company. It is a fortune 1000 ethanol producer. The company produces, markets and distributes ethanol. It also produces co-products along with ethanol such as wet, …
  • Zoo Digital Group plc (ZOO):企業概要、財務及び戦略的SWOT分析
    Summary ZOO Digital Group plc (ZOO) is an information technology company. The company creates media for global distribution, labour-intensive and time-consuming process. Its products include ZOOsubs, ZOOcore, ZOOpost, and ZOOdubs. ZOOcore is a cloud-based platform licensed as software-as-a-service t …
  • Encision Inc. (ECIA):企業の財務及び戦略的SWOT分析
    Summary Encision Inc. (Encision) is a medical equipment company that offers surgical instrument. The company offers laparoscopic monopolar surgical instruments. Its products include AEM burn protection systems, AEM instrumentation, cord adapter, inhibit adapter extension, monitor setup, monitor alar …
  • Global Petroleum Limited (GBP):企業財務及び戦略的SWOT分析
    Summary Global Petroleum Limited (Global Petroleum) is an oil and gas company that provides exploration services. The company operates through a portfolio of oil and gas projects in offshore Namibia and others. Its Namibian Project is into petroleum and gas exploration and Juan de Nova Project is in …
  • Kellstrom Defense Aerospace, Inc.:企業の戦略・SWOT・財務分析
    SummaryKellstrom Defense Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Straits Resources Limited (SRQ):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Straits Resources Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Horizon North Logistics Inc. (HNL):企業財務及び戦略的SWOT分析
    Summary Horizon North Logistics Inc. (HNL) is a resource development service company that offers service camps and catering, manufacturing, and transportation and logistics services. The company provides camps and catering service open lodges, rental fleet, catering and housekeeping services, camp a …
  • Novartis Pharmaceuticals Corporation(製薬・医療分野):企業M&A動向
    Summary Novartis Pharmaceuticals Corporation (NPC) is a pharmaceuticals company. The company carries out research, development and marketing of the pharmaceutical ingredients for healthcare industry. It offers products such as afinitor, amturnide, arcapta neohaler, cataflam, clozaril, coartem, combi …
  • Antibe Therapeutics Inc (ATE)-製薬・医療分野:企業M&A・提携分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercialize novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen …
  • Elecnor S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Elecnor S.A. Mergers and Acquis …
  • Amaya Inc.:企業のM&A・提携・投資分析
    Amaya Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amaya Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Vyteris, Inc.(製薬・医療分野):企業M&A動向
    Summary Vyteris, Inc. (Vyteris) is a biotechnology company. The company discovers, develops, and manufactures transdermal medication delivery products, which delivers drugs through skin using low-level electrical energy. Its product includes LidoSite. Vyteris’s lidosite is a lidocaine HCl/epinephrin …
  • Mirna Therapeutics, Inc.:製品開発パイプライン動向2015
    Mirna Therapeutics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Mirna Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Mirna Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information …
  • Bukwang Pharm.Co., Ltd. (003000):企業の財務及び戦略的SWOT分析
    Summary Bukwang Pharm.Co., Ltd. (BUKWANG) is a pharmaceutical company that develops therapies. The company discovers and develops pharmaceutical products. It offers Levovir, Thioctacid, Legalon, Azeptin, and Asima, among others. BUKWANG’s pipeline products include Apatinib Mesylate, MLR-1023, and BK …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆